<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38348">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01705522</url>
  </required_header>
  <id_info>
    <org_study_id>COL-GASTRO-3</org_study_id>
    <nct_id>NCT01705522</nct_id>
  </id_info>
  <brief_title>Multimodal Approach in IBD Patients</brief_title>
  <acronym>MAID</acronym>
  <official_title>Multimodal Approach in IBD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Colentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Hospital Colentina</source>
  <oversight_info>
    <authority>Romania: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators intend to assess the role of several biomarkers in the prediction of
      relapse in IBD. Clinical, laboratory and endoscopic data will be gathered and a predictive
      score will be derived in order to assess the relapse risk at 1 year.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Clinical relapse</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>clinical relapse as assessed by conventional scores for activity in IBD - Mayo or CDAI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of NAFLD</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>to assess the prevalence of nonalcoholic liver disease in IBD patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>prevalence of vitamin D deficiency</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>to assess vitamin D deficiency and osteopenia among IBD patients</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Crohn's Disease</condition>
  <condition>Nonalcoholic Fatty Liver Disease (NAFLD)</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>IBD patients</arm_group_label>
    <description>patients with ulcerative colitis or crohn's disease, in remission</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum and fecal samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        all patients with IBD over 18 years of age, currently in clinical remission
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ulcerative colitis or Crohn's disease

          -  age over 18

          -  clinical remission

          -  signed informed consent

        Exclusion Criteria:

          -  pregnant women

          -  refusal to sign informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodor Voiosu, Md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Hospital Colentina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Theodor A Voiosu, MD</last_name>
    <phone>0040726732764</phone>
    <email>theodor.voiosu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Colentina Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreea Bengus, MD</last_name>
      <phone>0040744497626</phone>
      <email>andreeabengus@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Theodor A Voiosu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <reference>
    <citation>Dionne S, Hiscott J, D'Agata I, Duhaime A, Seidman EG. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci. 1997 Jul;42(7):1557-66.</citation>
    <PMID>9246063</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 23, 2013</lastchanged_date>
  <firstreceived_date>October 10, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Colentina</investigator_affiliation>
    <investigator_full_name>dr. Theodor Alexandru Voiosu</investigator_full_name>
    <investigator_title>Gastroenterology resident, Teaching Assistant</investigator_title>
  </responsible_party>
  <keyword>IBD</keyword>
  <keyword>ulcerative colitis</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>NAFLD</keyword>
  <keyword>biomarkers</keyword>
  <keyword>vitamin D</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
